SCHEMBL20152515

SCHEMBL20152515

CC(C)N(c1ccccc1-c1ccccc1)c1ccccc1-c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC25B P30305 2/20 0.40
CDC25A P30304 1/20 0.40
PTGS2 P35354 2/20 0.39
BACE1 P56817 1/20 0.39
ADRA2A P08913 2/20 0.38
ADRA2B P18089 2/20 0.38
ADRA2C P18825 2/20 0.38
ALDH1A1 P00352 6/20 0.38
HSD17B10 Q99714 2/20 0.38
MAPK1 P28482 2/20 0.38
HPGD P15428 1/20 0.38
BCL2L1 Q07817 1/20 0.38
CYP2A6 P11509 1/20 0.38
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37
MAPT P10636 3/20 0.37
HTT P42858 2/20 0.37
NPSR1 Q6W5P4 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24206220 0.91 SLC6A2 (0.37) CDC25BCDC25APTGS2BACE1ADRA2A
SCHEMBL23776042 0.90 ALDH1A1 (0.39) CDC25BCDC25APTGS2BACE1ADRA2A
SCHEMBL20152513 0.87 MAPT (0.38) CDC25BCDC25APTGS2BACE1ALDH1A1
SCHEMBL20199430 0.87 MAPT (0.38) CDC25BCDC25APTGS2BACE1ALDH1A1
SCHEMBL24359328 0.83 KMT2A (0.41) CDC25BCDC25APTGS2BACE1ALDH1A1
SCHEMBL13371565 0.81 ALDH1A1 (0.37) PTGS2ADRA2AADRA2BADRA2CALDH1A1
SCHEMBL25784107 0.81 HTR7 (0.42) CDC25BCDC25APTGS2BACE1ADRA2A
SCHEMBL23920581 0.77 LMNA (0.37) ADRA2AADRA2BADRA2CALDH1A1MAPT
SCHEMBL26487517 0.76 PTGS2 (0.39) CDC25BCDC25APTGS2BACE1ALDH1A1
SCHEMBL6723948 0.75 MEN1 (0.45) PTGS2BACE1ALDH1A1HSD17B10MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11737354-B2 Organic light emitting device having a carbazole-based compound formed between a cathode and a light emitting layer and a spirobifluorene-monoamine-based compound formed between an anode and a light emitting layer LG CHEM, LTD. (KR) 2023-08-22 US disclosed
US-20200295264-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2020-09-17 US disclosed
US-10580996-B2 Polycyclic compound and organic light-emitting element comprising same LG CHEM, LTD. (KR) 2020-03-03 US disclosed
US-20180138421-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-17 US disclosed
US-20180138421-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200295264-A1 ORGANIC LIGHT EMITTING DEVICE TPH1, DRD1, CYP1A1 CDC25B 1680/4885CDC25A 1965/4885PTGS2 3258/4885
US-20180138421-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME CRY2, NR2E3, CRY1 CDC25B 2467/4885CDC25A 2776/4885PTGS2 2305/4885
US-10580996-B2 Polycyclic compound and organic light-emitting element comprising same CRY2, NR2E3, CRY1 CDC25B 2467/4885CDC25A 2776/4885PTGS2 2305/4885
US-11737354-B2 Organic light emitting device having a carbazole-based compound formed between a cathode and a light emitting layer and a spirobifluorene-monoamine-based compound formed between an anode and a light emitting layer DRD1, TPH1, DRD3 CDC25B 1665/4885CDC25A 1792/4885PTGS2 3844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.